Savvy Updates 7/1/24: Senseonics 365-day CGM, Dana Lewis on Exocrine Pancreatic Insufficiency, Apple/Fitbit/Garmin & Bacteria, Low-Dose SGLT2 Inhibitor May Protect Kidneys, Dual GLP-1 & Glucagon Agonist Pemvidutide, How GLP-1 Receptor Agonists Work

Savvy Updates 7/1/24: Senseonics 365-day CGM, Dana Lewis on Exocrine Pancreatic Insufficiency, Apple/Fitbit/Garmin & Bacteria, Low-Dose SGLT2 Inhibitor May Protect Kidneys, Dual GLP-1 & Glucagon Agonist Pemvidutide, How GLP-1 Receptor Agonists Work

Jul 1, 2024 | Diabetes Business, Podcasts, Research News, Technology Updates

Senseonics tips 365-day CGM to double 2025 sales by Nick Paul Taylor for MedTechDive.com, 25 June 2024. In 2024, Senseonics expects to more than double U.S. new patient starts and increase the global installed base by around 50%. The growth is built on the current...
Savvy Updates, 7/24/23: Exocrine Pancreatic Insufficiency, Dahlias & T1D, Volagidemab (GCGR), Pharma Sues Medicare, CODEX the Gut, Tight Control OK for Retinopathy, Early Risers vs. Night Owls, Overcoming Burnout

Savvy Updates, 7/24/23: Exocrine Pancreatic Insufficiency, Dahlias & T1D, Volagidemab (GCGR), Pharma Sues Medicare, CODEX the Gut, Tight Control OK for Retinopathy, Early Risers vs. Night Owls, Overcoming Burnout

Jul 24, 2023 | Eating, Featured, Research News, Technology Updates, Videos

New Systematic Review of Exocrine Pancreatic Insufficiency (EPI) In Type 1 Diabetes and Type 2 Diabetes – Focusing on Prevalence and Treatment by Dana Lewis for DIYPS.org, 13 July 2023.         I’m thrilled that the research I did evaluating the...
Skip to content